Impact of Treatment of Gastroesophageal Reflux on Obstructive Sleep Apnea-Hyponea Syndrome

Friedman M, Gurpinar B, Lin HC, Schalch P, Joseph N. Ann Otol Rhinol Laryngol. 2007 Nov;116(11):805-11.

OBJECTIVES: We test the hypothesis that treatment of gastroesophageal reflux disease (GERD) can improve obstructive sleep apnea-hypopnea syndrome (OSAHS).

RESULTS: Forty-one patients completed single-dose treatment with esomeprazole, but the repeat 24-hour pH study showed that 9 patients had persistent GERD. In the 29 patients who completed phase 2 with normal pH study findings, the snoring level decreased from 9.7 +/- 0.5 to 7.9 +/- 1.3 (p < .0001), the Epworth Sleepiness Scale score decreased from 14.2 +/- 2.5 to 11.1 +/- 2.4 (p < .0001), the apnea-hypopnea index decreased from 37.9 +/- 19.1 to 28.8 +/- 11.5 (p = .006), and the minimum saturation of oxygen increased from 84.1% +/- 7.8% to 86.9% +/- 5.0% (p = .055).

CONCLUSION: Treatment of GERD had a significant impact on the reduction of the apnea-hypopnea index, snoring, and daytime sleepiness. Elimination of GERD should be part of a comprehensive treatment plan for patients with OSAHS.

 

Topics: pH monitoring, ENT, sleep, PPI, 2007

Clinical Library

Quick access to relevant clinical news.

Here is our collection of clinical abstracts, clinician and researcher presentations and other relevant clinical news related to Restech's pH system. You will also find various research and insights covering the reflux spectrum from diagnostics to medical and surgical interventions. Stay tuned for updates!